Effect of Antagonism of Mivacurium-Induced Neuromuscular Block on Postoperative Emesis in Children
- 1 April 1995
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 80 (4) , 713-717
- https://doi.org/10.1097/00000539-199504000-00011
Abstract
The routine use of cholinesterase inhibitors to antagonize residual neuromuscular block may be associated with increased postoperative emesis.Rapid spontaneous recovery from mivacurium may obviate the need for these drugs. In this randomized, double-blind, placebo-controlled study of 113 healthy children who had received mivacurium as part of a standardized anesthetic regimen, we compared the incidence of postoperative complications after spontaneous recovery and after the use of neostigmine-glycopyrrolate or edrophonium-atropine. The anesthetic regimen consisted of halothane, nitrous oxide, fentanyl, 2 micro gram/kg intravenous (IV), mivacurium in an initial dose of 0.2 mg/kg, followed by an infusion, adjusted to maintain >or=to1 evoked contraction response to a supramaximum train-of-four stimulus. At the end of the procedure, patients received by random assignment one of three drug combinations: 1) neostigmine 70 micro gram/kg + glycopyrrolate 10 micro gram/kg, IV, 2) edrophonium 1 mg/kg + atropine 10 micro gram/kg, IV, and 3) saline. The trachea was extubated when evoked responses to peripheral nerve stimulation and clinical signs of adequate neuromuscular recovery were present. Postoperative pain was treated with morphine and emesis with metoclopramide. There were no significant differences between the three groups with respect to age, surgery, intraoperative fentanyl, and mivacurium use, time from the end of surgery to tracheal extubation, postanesthesia care unit (PACU) arrival and discharge, or in postoperative oxygen saturation values and analgesic requirements. Compared to the placebo group, emesis occurred more often in the PACU in patients receiving the neostigmine-glycopyrrolate combination, but not after edrophonium-atropine. However, after discharge from the PACU, emesis rates were similar in the three study groups. We conclude that spontaneous recovery or reversal with edrophonium from a moderate degree of mivacurium-induced block may offer advantages over the use of neostigmine, without increasing time to PACU arrival. (Anesth Analg 1995;80:713-17)Keywords
This publication has 12 references indexed in Scilit:
- Cholinesterase inhibitors do not prolong neuromuscular block produced by mivacuriumBritish Journal of Anaesthesia, 1994
- Use of Mivacurium During Laparoscopic SurgeryAnesthesia & Analgesia, 1994
- DOSE-RESPONSE RELATIONSHIPS FOR EDROPHONIUM AND NEOSTIGMINE ANTAGONISM OF MIVACURIUM-INDUCED NEUROMUSCULAR BLOCKBritish Journal of Anaesthesia, 1993
- Mivacurium‐induced neuromuscular blockade in patients with atypical plasma cholinesteraseActa Anaesthesiologica Scandinavica, 1993
- Reversal of Neuromuscular BlockadeAnesthesiology, 1992
- NEUROMUSCULAR BLOCKADE REVERSAL AGENTS INDUCE POST-OPERATIVE NAUSEA AND VOMITINGAnesthesiology, 1992
- NEUROMUSCULAR AND CLINICAL EFFECTS OF MIVACURIUM CHLORIDE IN HEALTHY ADULT PATIENTS DURING NITROUS OXIDE-ENFLURANE ANAESTHESIA †British Journal of Anaesthesia, 1991
- INFLUENCE OF NEOSTIGMINE ON POSTOPERATIVE VOMITINGBritish Journal of Anaesthesia, 1988
- Comparison of Caudal and Ilioinguinal/iliohypogastric Nerve Blocks for Control of Post-orchiopexy Pain in Pediatric Ambulatory SurgeryAnesthesiology, 1987
- Effect of Neostigmine on Integrity of Ileorectal AnastomosesBMJ, 1968